Physician Assistant · Royal Oak, MI
NPI
1841660412
Since 2015
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
221 S Main St Ste 201
Royal Oak, MI, 48067
Phone (747) 208-5003
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
615 services
Medicare patients, 2024
80
Average age 62
Drug cost, 2024
$1.0M
3,697 prescriptions
Company payments, 2025
$162K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarang Patel was code 99214 (office e&m - established), 595 times for 78 patients. In total Sarang Patel billed 615 services in 5 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 595 | 78 | $66.50 | $40K |
By year: 2022 $62K for 866 services; 2023 $43K for 653 services; 2024 $41K for 615 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarang Patel prescribed most often to Medicare patients was Alprazolam, with 265 prescriptions and refills. In total Sarang Patel wrote 3,697 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 265 | 265 | 34 | $1,014 |
| Trazodone Hcl Generic | 233 | 274 | 40 | $2,161 |
| Quetiapine Fumarate Generic | 197 | 267 | 36 | $1,544 |
| Clonazepam Generic | 175 | 183 | 26 | $901 |
| Sertraline Hcl Generic | 139 | 191 | 26 | $1,544 |
| Auvelity Dextromethorphan Hbr/Bupropion | 135 | 135 | 25 | $125K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 120 | 120 | 13 | $3,637 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 112 | 192 | 20 | $2,500 |
| Vraylar Cariprazine Hcl | 103 | 103 | 17 | $143K |
| Escitalopram Oxalate Generic | 95 | 117 | 16 | $898 |
| Prazosin Hcl Generic | 93 | 103 | 14 | $1,041 |
| Zolpidem Tartrate Generic | 90 | 96 | 14 | $543 |
| Duloxetine Hcl Generic | 88 | 126 | 13 | $2,012 |
| Lamotrigine Generic | 87 | 126 | 15 | $718 |
| Quviviq Daridorexant Hcl | 82 | 82 | 17 | $40K |
Brand drugs: - claims; generic drugs: 3,022 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarang Patel $162K ($162K in general payments such as food, travel and fees) from 12 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $87K.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 128 | $87K |
| Axsome Therapeutics, Inc. AXSM | 40 | $22K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 49 | $19K |
| Abbvie Inc. ABBV | 40 | $12K |
| Vanda Pharmaceuticals Inc. VNDA | 18 | $8,105 |
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $6,141 |
| Alkermes, Inc. ALKS | 12 | $5,835 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $979 |
| Lundbeck LLC | 2 | $30.19 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $19.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.